April User Fee Goal Calendar: Forecast Uncertain For Atopic Dermatitis Candidates, Nuplazid; Eohilia Could Be First For Orphan Use

 
• By Bridget Silverman

While some of the most prominent applications with user fee goal dates in April could be delayed, thanks to JAK inhibitor safety concerns and US FDA communications, the upcoming month should see more than 15 decisions on applications.

Shutterstock - 661293361 Rain falling and colorful umbrella in rainy day
Sponsors could be showered with a range of approvals in April. • Source: Shutterstock

More from Complete Response Letters

More from Product Reviews